Large pharmaceutical companies are more profitable than most companies in the S&P 500 according to a study published in the Journal of the American Medical Association. Pharmaceutical profits were closer to those of other research-based companies within the S&P 500 and were not higher than companies in the technology sector. The study from the Center for Integration of Science and Industry at Bentley University is the first to critically examine the profitability of pharmaceutical companies.
New research reveals pharma companies are more profitable than most S&P 500 companies
- 3. 3 2020 (06:00)